King Pharmaceuticals KG Ratios & Valuation
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | ||
|---|---|---|---|---|---|
| Leverage | |||||
| Debt-to-equity | 1.5×— | —— | —— | —— | |
| Per Share | |||||
| Book value per share | $15.66+919% | $22.38— | $18.57— | $32.38— | |
| Valuation | |||||
| Market capitalization | $70.42M-71.3% | —— | —— | —— | |
| Price / sales | 1.6×-27.7× | —— | —— | —— | |
| Price / book | 0.6×-1.1× | —— | —— | —— |
Questions, answered.
- Where do King Pharmaceuticals's ratios come from?
- Every ratio is computed from King Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
